Przejdź do zawartości
Merck

LC/MS Analysis of Clenbuterol In Plasma on Astec® CHIROBIOTIC® T with Phospholipid Removal using HybridSPE® Phospholipid

LC/MS Analysis of Clenbuterol In Plasma on Astec® CHIROBIOTIC® T with Phospholipid Removal using HybridSPE® Phospholipid application for SPE, application for LC-MS

Materiały

Zastosowanie

Numer produktu
Opis
Cennik

HPLC Analysis of Clenbuterol Enantiomers on Astec® CHIROBIOTIC® T

application for HPLC

HPLC Analysis of Clenbuterol Enantiomers on Astec® CHIROBIOTIC® T2

application for HPLC

kolumna analityczna

Numer produktu
Opis
Cennik

Astec® CHIROBIOTIC® T Chiral HPLC Column

5 μm particle size, L × I.D. 10 cm × 2.1 mm

probówka lub płytka SPE

Numer produktu
Opis
Cennik

HybridSPE®-Phospholipid

96-well Plate, bed wt. 50 mg, volume 2 mL, pk of 1

standardowe

Numer produktu
Opis
Cennik

Clenbuterol hydrochloride

≥95%

CONDITIONS

sample preparation

SPE (Solid Phase Extraction)

sample/matrix

rat plasma spiked with clenbuterol enantiomers at 10 ng/mL

SPE well plate

HybridSPE-Precipitation 96-well Plate, 50 mg/well (575656-U)

sample addition

100 μL spiked rat plasma followed by 300 μL 1% formic acid in acetonitrile. Mix by vortexing the HybridSPE-PPT plate briefly.

elution

apply vacuum

column

CHIROBIOTIC T, 10 cm x 2.1 mm I.D., 5 μm particles (12018AST)

mobile phase

10 mM ammonium formate in methanol

flow rate

0.3 mL/min

column temp.

30 °C

detector

ABI 3200 QT; ESI(+), MRM: 184/104 m/z (phospholipids); 277.2/203.1 m/z (clenbuterol)

injection

10 μL

Opis

Zastosowanie

The HybridSPE method provides significant improvement in LC-MS baseline.

Informacje prawne

Astec is a registered trademark of Merck KGaA, Darmstadt, Germany
CHIROBIOTIC is a registered trademark of Sigma-Aldrich Co. LLC
HybridSPE is a registered trademark of Merck KGaA, Darmstadt, Germany